Benzimidazole-D-ribonucleosides as antiviral agents that target HCMV terminase

New Concepts of Antiviral Therapy

Volumn , Issue , 2006, Pages 337-349

  Drach, John C ^a   Townsend, Leroy B ^a   Bogner, Elke ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84919871945     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-31047-3_12     Document Type: Chapter

References (33)

1. Beavan G. R., Holiday E. R., Johnson E. A., Ellis B., Mamalis P., Petrow V. and Sturgeon B. 1949, The chemistry of anti-pernicious anaemia factors Part III. 5:6-Disubstituted benzimidazoles as products of acid hydrolysis of vitamin B12. J. Pharmacy Pharmacol. 1949;1:957-970
2. Bogner, E., 2002, Human cytomegalovirus terminase as a target for antiviral chemotherapy. Rev. Med. Virol. 12:115-127
3. Bogner, E., Radsak, K., and Stinski, M. F,. 1998, The gene product of human cytomegalovirus open reading frame UL56 binds the pac motif and has specific nuclease activity. J. Virol. 72:2259-2264
4. Britt, W. J. and Alford, C. A., 1996, Cytomegalovirus. In Fields Virology (N. Fields, D. M., Knipe, and P. M. Howley, eds.), 3th ed. Lippincott Williams and Wilkins, Philadelphia, pp. 2493-2523
5. Chulay, J., Biron, K. Wang, L. Underwood, M., Chamberlain, S., Frick, L., Good, S., Davis, M., Harvey, R., Townsend, L., Drach, J., and Koszalka, G., 1999 Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus disease. Adv. Exp. Med. Biol. 458:129-134
6. Dittmer, A. and Bogner, E., 2005, Analysis of the quaternary structure of the putative HCMV portal protein pUL104. Biochemistry 44:759-765
7. Dittmer, A., Drach, J. C., Townsend, L. B., Fischer, A. and Bogner, E., 2005, Interaction of the putative HCMV portal protein pUL104 with the large terminase subunit pUL56 and its inhibition by Benzimidazole-D-Ribonucleosides. J. Virol. 79: in press
8. Good, S. S., Owens, B. S., Townsend, L. B. and Drach, J. C., 1994, The disposition in rats and monkey of 2-bromo-5, 6-dichloro-1-(β-D-ribofuranosyl)-benzimidazole (BDCRB) and its 2, 5, 6-trichloro congner (TCRB). Antiviral Research 23: Suppl. I, 103
9. Gudmundsson, K. S., Drach, J. C., Wotring, L. L., and Townsend, L. B., 1997, Synthesis and antiviral activity of certain 5'-modified analogs of 2, 5, 6,-trichloro-1-(β-D-ribofuranosyl) - benzimidazole (TCRB). J. Med. Chem. 40:785-793
10. Hwang, J.-S. and Bogner, E,. 2002, ATPase activity of the terminase subunit pUL56 of human cyto megalovirus. J. Biol. Chem. 27:6943-6948
11. Komazin, G., Townsend, L. B. and Drach, J. C., 2004, Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides. J. Virol. 78:710-715
12. Krosky, P. M., Underwood, M. R., Turk, S. R., Feng, K. W.-H., Jain, R. K., Ptak, R. G., Westerman, A. C., Biron, K. K., Townsend, L. B. and Drach, J. C., 1998, Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J. Virol. 72:4721-4728
13. Krosky P. M., Borysko K.., Nassiri M. R., Devivar R. V., Ptak R. G., Davis M. G., Biron K. K., Townsend L. B., Drach J. C., 2002, Phosphorylation of β-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus. Antimicrob. Agents Chemother. 46:478-486
14. Mettenleiter, TC., 2002, Herpesvirus assembly and egress. J. Virol. 76:1537-1547
15. Mocarski, E. S., Jr,. 1996, Cytomegalovirus and their replication. In Fields Virology (N. Fields, D. M., Knipe, and P. M. Howley, eds.), 3th ed. Lippincott Williams and Wilkins, Philadelphia., pp. 2447-2492
16. Nassiri, M. R., Emerson, S. G., Devivar, R. V., Townsend, L. B., Drach, J. C., and Taichman, R. S., 1996, Comparison of benzimidazole nucleosides and ganciclovir on the in vitro proliferation and colony formation of human bone marrow progenitor cells. Brit. J. Haematol. 93:273-279
17. Nixon, D. E. and McVoy, M. A., 2004, Dramatic effects of 2-bromo-5, 6-dichloro-1-beta-D-ribofuranosyl benzimidazole on the genome structure, packaging, and egress of guinea pig cytomegalovirus. J. Virol. 78:1623-1635
18. North, T. W., Sequar, G., Townsend, L. B., Drach, J. C., and Barry, P. A., 2004, Rhesus cytomegalovirus is similar to human cytomegalovirus in susceptibility to benzimidazole nucleosides. Antimicrob. Agents Chemother. 48:2760-2765
19. Radsak, K., Eickmann, M., Mockenhaupt, T., Bogner, E., Kern, H., Eis-Hübinger, A. and Reschke, M., 1996, Retrieval of human cytomegalovirus glycoprotein B from infected cell surface for virus envelopment. Arch. Virol. 141:557-572
20. Roizman, B. and Knipe, D., 2001, Herpes simplex viruses and their replication. In Fields Virology (D. M., Knipe, and P. M. Howley, eds.), 3th ed. Lippincott Williams and Wilkins, Philadelphia, pp. 2399-2460
21. Savva, C. G. W., Holzenburg, A. and Bogner, E., 2004, Three-dimensional structure of the terminase subunit pUL56 of human cytomegalovirus. FEBS Lett. 563:135-140
22. Scheffczik, H., Savva, C. G. W., Holzenburg, A., Kolesnikova, L. and Bogner, E., 2002, The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure. Nuc Acids Res. 30:1695-1703
23. Scholz, B., Rechter, S., Drach, J. C., Townsend, L. B. and Bogner, E., 2003, Identification of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus. Nuc. Acids Res. 31:1426-1433
24. Smith, D.e., Tans, S: J., Smith, S. B., Frimes, S., Anderson, D. L. and Bustamante, C., 2001, The bacteriophage straight phi29 portal motor can package DNA against an internal force. Nature 413:748-752
25. Tamm I., Folkers K., Shunk C. H., Horsfall F. L., 1954, Inhibition of influenza virus multiplication by n-glycosides of benzimidazoles. J. Exp. Med. 99:227-250
26. Tamm I. and Sehgal P. B., 1978, Halobenzimidazole ribosides and RNA synthesis of cells and viruses. Adv. Virus Res. 22:187-258
27. Townsend L. B. and Revankar G. R., 1970, Benzimidazole nucleosides, nucleotides, and related derivatives. Chem. Rev. 70:389-438
28. Townsend L. B., Devivar R. V., Turk S. R., Nassiri M. R., and Drach J. C., 1995, Design, synthesis and antiviral activity of certain 2, 5, 6-trihalo-1-(β-D-ribofuranosyl) benzimidazoles. J. Med. Chem., 38:4098-4105
29. Townsend, L. B., Drach, J. C., Good, S. S., Da Luge, S. M., and Martin, M. C., 1996, Therapeutic Nucleosides. U. S. Patent 5, 534, 535 issued 7/9/96.
30. Townsend, L. B., Gudmundsson, K. S., Daluge, S. M., Chen, J. J., Zhu, Z., Koszalka, G. W., Boyd, L., Chamberlain, S. D., Freeman, G. A., Biron, K. K., and Drach, J. C., 1999, Studies designed to increase the stability and antiviral activity (HCMV) of the active benzimidazole nucleoside, TCRB. Nucleosides and Nucleotides, 18:509-519
31. Underwood, M. R., Harvey, R. J., Stanat, S. C., Hemphill, M. L., Miller, T., Drach, J. C., Townsend, L. B. and Biron, K. K., 1998, Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. J. Virol. 72:717-72
32. Underwood, M. R., Ferris, R. G., Selleseth, D. W., Davis, M. G., Drach, J. C., Townsend, L. B., Biron, K. K. and Boyd, F. L., 2004, Mechanism of Action of the Ribopyranoside Benzimidazole GW275175X Against Human Cytomegalovirus. Antimicrob. Agents Chemother. 48:1647-1651
33. Zou, R., Drach, J. C. and Townsend, L. B., 1997 Design, Synthesis and Antiviral Evaluation of 2-Substituted 4, 5-Dichlro- and 4, 6-Dichloro-1-(β-D-ribofuranosyl) benzimidazoles as Potential Agents for Human Cytomegalovirus Infections. J. Med. Chem. 40:802-810